Rotigotine transdermal patch is the first transdermal non-ergot dopamine agonist, being a selective dopamine D1/D2/D3 receptor agonist [1-4]. Rotigotine patch is effective over 24 h and provides...
No takes yet. Share an insight, caveat, or question.
К. Ray Chaudhuri (2008) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: